Under settlement, FDA has to pre-approve Merck ads

One feature of Merck and Schering-Plough's settlement with 35 state attorneys general is a provision requiring the companies to get FDA to bless all its DTC advertisements--not just those for Vytorin, the cholesterol med that prompted the probe--before airing or publishing them. Report